Global pharma companies today face a critical challenge – accelerating innovation and strengthening pipelines while navigating complex regulatory environments and cost pressures. Key priorities include:
Global Capability Centers (GCCs) have become a strategic solution – enhancing productivity, reducing costs by up to 25% and driving competitive advantage
The key factors that have made India the backbone of global life sciences GCC operations include:
Today’s GCCs aren’t back-office operations. They’re innovation hubs contributing directly to drug discovery, digital therapeutics, and patient-centric breakthroughs.
Outsourcing providers simplify workforce capacity, but add 40-60% gross margins to every element. You lose visibility into actual costs, control over quality and processes, and cultural alignment between your strategic priorities and operational execution.
Direct cost control, full operational authority, and sustainable capability building, while optimizing spend by up to 25%. Modern GCCs are strategic innovation engines, not cost centers, contributing directly to pipeline acceleration and competitive differentiation.
Building a GCC isn’t just about hiring people and leasing office space. It’s about creating a sustainable capability that meets global regulatory standards, delivers predictable outcomes, and scales without quality erosion.
| What you get | Life Sciences GCC | Outsourcing providers |
|---|---|---|
| Cost structure | ~25% cost optimization | Provider builds gross margins of ~50+% into every element |
| Cost visibility | Full transparency on direct costs, indirect costs and overheads | Hidden markups, bundled fees and contract escalations |
| Operational control | Complete control over processes, SOPs and quality standards | Limited control – governed by outsourcing provider’s processes and quality |
| Compliance oversight | Direct audit trail and documentation under your control | Dependence on provider compliance which could lead to audit gaps |
| Talent access | Hire from our experienced talent pool or open market – your choice | Limited to provider’s bench with varying quality |
| Long-term stability | Build internal capability and reduce external dependency | Locked into outsourcing provider relationship and contract risks |
| Scalability | Scale as per your business needs with predictable costs | Scale subject capacity and pricing of the outsourcing provider |
| HQ Cultural alignment | Mirror the parent company ethos and decision-making DNA | Isolated satellites |
Consulting on functional scope, roles, SOPs, operations, governance, and KPIs for Pharmacovigilance, Clinical Operations, Quality Assurance, Regulatory Affairs, and Medical Writing GCCs.
Structured sourcing strategies and readiness programs to ensure consistent skill quality, compliance awareness, and delivery readiness across teams.
Site Selection, Workplace Design & Fit-Out Planning and Facilities & Operations Planning.
Technology Assessment & design coupled with Process Optimization, Automation and CoE establishment
Training and evaluation frameworks built to meet global regulatory expectations, audit standards, upskilling, and governance mechanisms and client delivery requirements.
People
Functional Talent strategy, hiring, competency frameworks
Process
Operating model design, SOP architecture, productivity benchmarking, governance frameworks
Technology
Digital enablement, automation, AI-led productivity, compliant tech stack selection
Infrastructure
Location strategy, facility design, compliance-ready infrastructure, scalability planning
Project management expertise for seamless execution across all pillars
| Where you are (Your current operating model) | Where you're going (Scaling your current operating model) | Building your own GCC (What you save) |
|---|---|---|
|
30 – 50 people Outsourced/in-house mix Spend of ~USD 1.5 - 2mn |
100-125 people Outsourced/in-house mix Spend of ~USD 3.5 – 4mn |
~USD 1mn annually Integrated GCC, full control 25% reduction |
|
Key functions: Clinical Trial Operations | Pharmacovigilance | Regulatory Affairs | Supply Chain Analytics | Biostatistics |
||